Cosmetic OEM / ODM product platform

Soothing Repair Peptide Microneedle Patch

Cosmetic soothing and barrier-care concepts for blemish-prone skin positioning.

HYTANBIO · Changzhou base

110-needle blemish microdart platform

The blemish platform uses HA arrays with 110 needles per patch and a nominal height range of 300–1,000 µm. Six packaging counts are listed: one, two, three, six, eight or nine patches. The geometry-led formulation reference contains salicylic acid, asiaticoside and PDRN; a separate botanical profile uses plant-derived salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate, with six-, eight- or nine-patch stock-pack references. Ingredient names matter: salicin is not salicylic acid, and madecassoside is not asiaticoside. Select a single approved formulation profile before sampling. PDRN identity, source, intended route and classification need specific review. The portfolio’s acne-care positioning must be checked for the launch market; product naming alone does not substantiate acne treatment. Backing, tray, size and color complete the product brief.

Blemish / acne microdart patch — HYTANBIO configuration

OEM / ODM configuration

Blemish / acne microdart patch

  • Array material: Hyaluronic acid (HA)
  • Nominal needle height: 300–1,000 µm
  • Needles per patch: 110
  • Patches per pack: 1 / 2 / 3 / 6 / 8 / 9
  • Backing options: PE / PU / TPU / hydrocolloid
  • Other options: Tray, size and color

Geometry-led blemish profile

Ingredient reference: Salicylic acid, asiaticoside and PDRN

Targeted blemish-patch research configuration

Botanical blemish-care profile

Ingredient reference: Plant-derived salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate

Blemish-prone skin and the appearance of post-blemish marks; catalogue acne-care positioning requires market review

Pack: 6 / 8 / 9 patches

Salicin and salicylic acid are different ingredients; asiaticoside and madecassoside are different ingredients. PDRN identity, source, quality and intended delivery route require a separate safety and classification assessment. No acne-treatment result is established.

Buyer questions

Which blemish pack sizes are listed?

The geometry-led format lists 1, 2, 3, 6, 8 or 9 patches per pack, with 110 needles per patch.

Are the two blemish formulations identical?

No. One lists salicylic acid, asiaticoside and PDRN; the other lists salicin, madecassoside, Sophora flavescens root extract and sodium hyaluronate. These are separate configurations.

Portfolio specifications updated October 15, 2026 · HYTANBIO product portfolio, pages 14, 16. Final configuration and evidence requirements are agreed per project.

Platform overview

Designed as a customizable commercial starting point

Core peptide direction

Candidate peptides are screened against intended positioning, compatibility, processing conditions and the final test plan. Final INCI and concentration are project-specific.

Microneedle specification

Needle height, array density, patch size and dissolution profile are selected for the cosmetic application area and manufacturing feasibility.

Private-label options

Custom logo, high-barrier pouch, retail carton, instructions and multipack configuration can be coordinated under one project.

What can be customized

Formula & performance brief

  • Single or multi-peptide blend direction
  • Supporting cosmetic ingredients
  • Concentration and compatibility targets
  • Stability and packaging test plan

Physical & brand specification

  • Patch shape and dimensions
  • Needle height and array pattern
  • Pouch, carton and logo artwork
  • Sample, pilot and mass-production route
All benefit statements are cosmetic positioning concepts. Final claims require substantiation and market-specific review of the finished product.
Original AI-generated concept imagery illustrates product formats, packaging and development topics. It does not document our premises, verify equipment ownership or establish efficacy, certification or regulatory approval.
✆
Scroll to Top